LT2805945T - Amidu pakeistieji indazolai, kaip poli(adp-ribozės)polimerazės (parp) inhibitoriai - Google Patents

Amidu pakeistieji indazolai, kaip poli(adp-ribozės)polimerazės (parp) inhibitoriai

Info

Publication number
LT2805945T
LT2805945T LTEP14176452.2T LT14176452T LT2805945T LT 2805945 T LT2805945 T LT 2805945T LT 14176452 T LT14176452 T LT 14176452T LT 2805945 T LT2805945 T LT 2805945T
Authority
LT
Lithuania
Prior art keywords
parp
adp
ribose
polymerase
inhibitors
Prior art date
Application number
LTEP14176452.2T
Other languages
English (en)
Lithuanian (lt)
Inventor
Jesus Maria Ontoria Ontoria
Rita Scarpeli
Carsten Schultz-Fademrecht
Philip Jones
Original Assignee
Msd Italia S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37809722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2805945(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Msd Italia S.R.L. filed Critical Msd Italia S.R.L.
Publication of LT2805945T publication Critical patent/LT2805945T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTEP14176452.2T 2007-01-10 2008-01-08 Amidu pakeistieji indazolai, kaip poli(adp-ribozės)polimerazės (parp) inhibitoriai LT2805945T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0700432.8A GB0700432D0 (en) 2007-01-10 2007-01-10 Therapeutic compounds
US92131007P 2007-04-02 2007-04-02

Publications (1)

Publication Number Publication Date
LT2805945T true LT2805945T (lt) 2019-06-25

Family

ID=37809722

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14176452.2T LT2805945T (lt) 2007-01-10 2008-01-08 Amidu pakeistieji indazolai, kaip poli(adp-ribozės)polimerazės (parp) inhibitoriai

Country Status (21)

Country Link
CN (1) CN101578279B (da)
AT (1) ATE502933T1 (da)
CR (1) CR10910A (da)
DE (1) DE602008005711D1 (da)
DK (2) DK2336120T3 (da)
ES (3) ES2728199T3 (da)
GB (1) GB0700432D0 (da)
HN (1) HN2009001260A (da)
HU (1) HUE044513T2 (da)
LT (1) LT2805945T (da)
LU (1) LUC00072I2 (da)
ME (1) ME03481B (da)
MY (1) MY147789A (da)
NI (1) NI200900135A (da)
NZ (1) NZ578256A (da)
PE (1) PE20081558A1 (da)
PT (3) PT2109608E (da)
SI (2) SI2109608T1 (da)
TW (1) TWI528961B (da)
UA (1) UA97658C2 (da)
ZA (1) ZA200903898B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106496187A (zh) * 2016-09-14 2017-03-15 陕西科技大学 一种制备PARP抑制剂Niraparib的合成方法
CN106432187A (zh) * 2016-09-17 2017-02-22 青岛云天生物技术有限公司 2‑[4‑(‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的手性拆分方法
CN106432188A (zh) * 2016-09-17 2017-02-22 青岛辰达生物科技有限公司 一种抗癌药2‑[4‑((3s)‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的制备方法
CN106632244A (zh) * 2016-09-30 2017-05-10 陕西科技大学 一种制备抗癌药物Niraparib的新型合成方法
CN106467513A (zh) * 2016-09-30 2017-03-01 陕西科技大学 一种制备Niraparib的合成方法
CN108201537A (zh) * 2016-12-16 2018-06-26 苏州苏融生物医药有限公司 一种尼拉帕尼缓控释药物组合物及其用途
KR20190130625A (ko) * 2017-03-27 2019-11-22 테사로, 인코포레이티드 니라파립 제제
CN109081828B (zh) * 2017-06-14 2021-03-26 上海时莱生物技术有限公司 聚(adp-核糖)聚合酶抑制剂、制备方法及用途
CA3076907A1 (en) 2017-09-26 2019-04-04 Tesaro, Inc. Niraparib formulations
CN108084157A (zh) * 2018-02-12 2018-05-29 安庆奇创药业有限公司 一种尼拉帕尼的合成方法
CN108203404A (zh) * 2018-03-02 2018-06-26 上海博邦医药科技有限公司 (r)-3-苯基哌啶或/和(s)-3-苯基哌啶以及尼拉帕尼的手性中间体的合成方法
US20240016775A1 (en) 2020-02-24 2024-01-18 Fukang (Shanghai) Health Technology Co., Ltd Anti-coronavirus application of poly adp ribose polymerase inhibitor
CN115611860B (zh) * 2021-07-13 2024-06-11 上海博璞诺科技发展有限公司 合成尼拉帕尼的方法

Also Published As

Publication number Publication date
TW200836731A (en) 2008-09-16
ATE502933T1 (de) 2011-04-15
PT2109608E (pt) 2011-05-30
NZ578256A (en) 2011-12-22
GB0700432D0 (en) 2007-02-21
CN101578279A (zh) 2009-11-11
SI2109608T1 (sl) 2011-07-29
DE602008005711D1 (de) 2011-05-05
LUC00072I2 (fr) 2018-07-04
MY147789A (en) 2013-01-31
CR10910A (es) 2010-01-19
HUE044513T2 (hu) 2019-10-28
ES2509115T3 (es) 2014-10-17
ME03481B (me) 2020-01-20
UA97658C2 (ru) 2012-03-12
ZA200903898B (en) 2010-04-28
PT2336120E (pt) 2014-10-01
DK2109608T3 (da) 2011-07-11
HN2009001260A (es) 2012-03-26
PE20081558A1 (es) 2008-10-30
ES2728199T3 (es) 2019-10-22
PT2805945T (pt) 2019-06-06
SI2336120T1 (sl) 2014-10-30
NI200900135A (es) 2010-08-30
ES2362214T3 (es) 2011-06-29
DK2336120T3 (da) 2014-10-06
TWI528961B (zh) 2016-04-11
CN101578279B (zh) 2013-07-17

Similar Documents

Publication Publication Date Title
MX2009007200A (es) Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp).
ZA200903898B (en) Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors
MX2010005070A (es) Derivados de piridazinona como inhibidores de parp.
WO2007138351A3 (en) Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
MX2012002179A (es) Compuestos heterociclicos de oxima.
WO2008103277A3 (en) Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
ATE543811T1 (de) Pyridazinderivate als faktor-xia-inhibitoren
EA201190158A1 (ru) Производные бензофуранила для применения в качестве ингибиторов глюкокиназы
WO2010045251A3 (en) Spiro-oxindole compounds and their use as therapeutic agents
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
WO2008017883A3 (en) 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
EA201070864A1 (ru) Новые гетероциклические соединения
MX2012007582A (es) Compuestos de 4-fenoxi-nicotinamida o 4-fenoxi-pirimidina-5-carbox amida.
WO2011147951A8 (en) Cycloamino derivatives as gpr119 agonists
MX2011013869A (es) Agentes antihelminticos y su uso.
PH12015500418A1 (en) Pyridine derivative and medicine
GB201114389D0 (en) Novel compounds
UA101367C2 (en) Normal;heading 1;heading 2;heading 3;HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS